Company: RPID
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0001380106-25-000089
Chunk: 32

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 32
---
 extent required; and

• preparing the annual compensation committee report required by SEC rules, to the extent required.

The Compensation Committee charter is available on our website at investors.rapidmicrobio.com. The members of our Compensation Committee are Inese Lowenstein, Kirk D. Malloy, Ph.D. and Natale Ricciardi. Kirk D. Malloy, Ph.D. serves as the Chair of the Compensation Committee. Our Board has determined that each of Dr. Malloy, Ms. Lowenstein and Mr. Ricciardi is independent under the applicable Nasdaq rules, including the Nasdaq rules specific to membership on the compensation committee, and is a “non-employee director” as defined in Rule 16b-3 promulgated under the Exchange Act. The Compensation Committee may delegate its authority under its charter to a subcommittee as it deems appropriate from time to time.

The Compensation Committee met four (4) times during the fiscal year ended December 31, 2024.

#### Compensation Consultants
In fiscal year 2024, our management engaged Aon Consulting, Inc. (“Aon”), to continue to provide compensation consulting services. Since our initial public offering and the establishment of our Compensation Committee, Aon has continued to serve as a compensation consultant to management and the Compensation Committee. During fiscal year 2024, Aon’s services included advising on equity compensation programs, the development of the Company’s peer group and providing support and analysis regarding executive and director compensation. Aon also performed sales compensation and general employee salary and benefit consulting services for the Company in 2024. Our Compensation Committee has assessed the independence of Aon consistent with SEC rules and Nasdaq listing standards and has concluded that the engagement of Aon does not raise any conflict of interest.

### NOMINATING AND CORPORATE GOVERNANCE COMMITTEE
The Nominating and Corporate Governance Committee’s responsibilities include, among other things:

• identifying individuals qualified to become board members;

• recommending to our Board the persons to be nominated for election as directors and to each Board committee;

• developing and recommending to our Board corporate governance guidelines, and reviewing and recommending to our Board proposed changes to our corporate governance guidelines from time to time, including in connection with environmental, social and governance (ESG) considerations and corporate social responsibility (CSR) initiatives; and

• overseeing a periodic evaluation of our Board.

The Nominating and Corporate Governance Committee charter is available on our website at investors.rapidmicrobio.com. The members of our Nominating and Corporate